Feb 5 (Reuters) - CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for lower-cost ...

CVS Caremark identified four pipeline drugs that could reshape care delivery in 2026, with potential FDA approvals spanning weight management, diabetes, breast cancer and emergency allergy treatment.

CVS Health reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business saw higher medical costs. The company also issued a full-year 2025 adjusted profit ...

CVS plans to launch a cost-based drug pricing method for its retail pharmacies to bolster flatlining growth, executives announced during the company’s investor day on Tuesday. It’s a significant ...

CVS Health shares fell sharply in early Wednesday trading after the retail pharmacy and health insurance giant slashed its full-year profit forecasts amid soaring medical costs and the expected impact ...

CVS executives say healthcare delivery is more integrated when the CVS pharmacy and the Oak Street health centers for seniors are “side by side.” The new Oak Street format is being deployed this year ...

CVS Health reported mixed third-quarter results as higher medical costs squeezed its bottom line. The company expects elevated medical costs to continue to pressure its performance this year, "and as ...

GREENSBORO, N.C. (CN) - CVS Caremark, the nation's dominant pharmacy chain, uses and abuses the patient information it gets from handling prescriptions from competing pharmacies, by selling the ...

Nov 1 (Reuters) - CVS Health Corp (CVS.N), opens new tab tempered its forecast for 2024 earnings on Wednesday to account for potentially higher medical costs at its insurance unit as older adults ...